Structure

InChI Key HAYYBYPASCDWEQ-UHFFFAOYSA-N
Smile CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1
InChI
InChI=1S/C31H34F2N6O2/c1-38-8-10-39(11-9-38)25-3-4-26(29(19-25)34-24-6-12-41-13-7-24)31(40)35-30-27-17-20(2-5-28(27)36-37-30)14-21-15-22(32)18-23(33)16-21/h2-5,15-19,24,34H,6-14H2,1H3,(H2,35,36,37,40)

Physicochemical Descriptors

Property Name Value
Molecular Formula C31H34F2N6O2
Molecular Weight 560.65
AlogP 5.03
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 7.0
Polar Surface Area 85.52
Molecular species NEUTRAL
Aromatic Rings 4.0
Heavy Atoms 41.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR ALK tyrosine kinase receptor inhibitor FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 4 D009369 ClinicalTrials
Neoplasms 4 D009369 ClinicalTrials
Melanoma 2 D008545 ClinicalTrials
Carcinoma, Lobular 2 D018275 ClinicalTrials
Glioma 1 D005910 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 1108743-60-7
ChEMBL CHEMBL1983268
DrugBank DB11986
DrugCentral 5345
FDA SRS L5ORF0AN1I
Guide to Pharmacology 8290
PDB YMX
PubChem 25141092
SureChEMBL SCHEMBL3512601
ZINC ZINC000043204146